Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Pediatrics Physician in Detroit, MI
NPI: 1295772788Primary Practice Location
CHILDREN'S HOSPITAL OF MICHIGAN
3901 Beaubien St, Detroit, MI
Primary Employer
University Pediatricians
universitypediatricians.org
HQ Phone
Get M.D. Jeffrey's Phone Numberphone_androidMobile
Get M.D. Jeffrey's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
1988 - 2026
MI State Medical License
American Board of Pediatrics
Pediatrics
American Board of Pediatrics
Pediatric Hematology-Oncology
Children's Hospital of Michigan
Fellowship • Pediatric Hematology/Oncology
Until 1994
DMC Children's Hospital of Michigan
Until 1991
University of Western Ontario
MD • Medicine
1983 - 1987
Medical School
Until 1987
Incidence and outcomes of rare paediatric non-hodgkin lymphomas
Authors: Knight, Tristan E, Ge, Yubin, Taub, Jeffrey W, Hitzler, Johann, Krueger, Joerg
Journal: Pediatr Blood Cancer
Publication Date: 2021-08-06
Lead Sponsor: St. Jude Children's Research Hospital
Collaborators: Amgen, Incyte Corporation, Servier
Intervention / Treatment: DRUG: Vorinostat, DRUG: Doxorubicin, DRUG: Dexamethasone, DRUG: Cyclophosphamide, DRUG: Cytarabine, DRUG: Prednisone, DRUG: Etoposide, DRUG: Bortezomib, DRUG: Methotrexate, DRUG: Ruxolitinib, DRUG: Vincristine, DRUG: Blinatumomab, DRUG: Dasatinib, DRUG: Nelarabine, DRUG: Clofarabine, DRUG: Mercaptopurine, DRUG: Calaspargase Pegol, DRUG: Idarubicin, DRUG: Thioguanine, DRUG: Daunorubicin, DRUG: Pegaspargase, DRUG: Erwinase®, DRUG: Asparaginase Erwinia chrysanthemi (recombinant)-rywn
Lead Sponsor: Children's Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, BEHAVIORAL: Compliance Monitoring, DRUG: Mercaptopurine, PROCEDURE: Standard Follow-Up Care, BEHAVIORAL: Behavioral Intervention
Lead Sponsor: Children's Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: laboratory biomarker analysis, GENETIC: RNA analysis, GENETIC: reverse transcriptase-polymerase chain reaction
